Multidrug-Resistant Reference Materials

Drug resistance is on the rise

Multidrug resistance (MDR) is a serious health concern that has contributed to increases in morbidity, mortality, and healthcare expense. Support the prevention and treatment of these infections with a complete set of solutions from ATCC:

  • Strains from various clinical and environmental sources
  • Primary cells for drug toxicity screening studies
  • Media and reagents to support cellular growth

These products are ideal for the development, verification, and evaluation of rapid detection methods, innovative therapeutic techniques, novel antibiotics, and updated sterility protocols. Check out the resources below to find products relevant to your research, or:

Download our white paper to learn more about the importance of antimicrobial-resistant reference strains in reducing the emergence and spread of MDR infections.

Download the white paper

MDR Strains

ATCC offers a wide array of clinically relevant MDR strains isolated from a variety of hospital- and community-acquired sources. These cultures are useful for studying the genetic variations between strain types, the in vitro evaluation of disinfectants and novel antimicrobials, and establishing the performance characteristics of molecular-based assays. Search for strains by category:

Microbial Panels

ATCC Microbial Panels enable faster, more intelligent choices when selecting cultures for microbial research. Our collection of MDR panels comprise ATCC Genuine Cultures® grouped together based on genetic markers conferring drug resistance, including vancomycin-resistant enterococci (VRE), methicillin-resistant Staphylococcus aureus (MRSA), carbapenem-resistant Enterobacteriaceae, and drug-resistant Candida albicans.

Browse our microbial panels

Primary Cells

During the development of novel antimicrobial drugs, it is imperative to ensure product quality, safety, and efficacy. In vitro testing using primary cells derived from various organ systems and donors can provide a quick mechanism for screening therapeutics for any potential toxic effects. To aid in your toxicity studies, ATCC offers a variety of primary cells procured from diverse tissue sources combined with matched and optimized reagents. 

Search our collection of primary cells